{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T05:45:29Z","timestamp":1792215929136,"version":"4.4.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.clbc.2026.08.011","type":"journal-article","created":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T23:25:29Z","timestamp":1787181929000},"page":"40-51","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cancer-Associated Fibroblasts-Derived Exosomal METTL3 Drives Breast Cancer Malignancy by Eliciting PABPN1 m6A Modification"],"prefix":"10.1016","volume":"26","author":[{"given":"Jun","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danfeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihua","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochen","family":"Zan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clbc.2026.08.011_bib0001","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1016\/S1470-2045(21)00462-9","article-title":"National health system characteristics, breast cancer stage at diagnosis, and breast cancer mortality: a population-based analysis","volume":"22","author":"Duggan","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clbc.2026.08.011_bib0002","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.clbc.2026.08.011_bib0003","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.omtn.2018.05.018","article-title":"The impact of lncRNA dysregulation on clinicopathology and survival of breast cancer: a systematic review and meta-analysis","volume":"12","author":"Tian","year":"2018","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.clbc.2026.08.011_bib0004","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1158\/2159-8290.CD-20-1808","article-title":"Therapeutic targeting of the tumor microenvironment","volume":"11","author":"Bejarano","year":"2021","journal-title":"Cancer Discov"},{"key":"10.1016\/j.clbc.2026.08.011_bib0005","doi-asserted-by":"crossref","first-page":"R921","DOI":"10.1016\/j.cub.2020.06.081","article-title":"The tumor microenvironment","volume":"30","author":"Anderson","year":"2020","journal-title":"Curr Biol"},{"key":"10.1016\/j.clbc.2026.08.011_bib0006","first-page":"13","article-title":"The role of tumor microenvironment in cancer metastasis: molecular mechanisms and therapeutic opportunities","author":"Neophytou","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.clbc.2026.08.011_bib0007","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.canlet.2015.02.018","article-title":"Cancer-associated fibroblasts: a multifaceted driver of breast cancer progression","volume":"361","author":"Luo","year":"2015","journal-title":"Cancer Lett"},{"key":"10.1016\/j.clbc.2026.08.011_bib0008","doi-asserted-by":"crossref","DOI":"10.3390\/cancers8020019","article-title":"Breast cancer-associated fibroblasts: where we are and where we need to go","volume":"8","author":"Buchsbaum","year":"2016","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.clbc.2026.08.011_bib0009","doi-asserted-by":"crossref","first-page":"7551","DOI":"10.1073\/pnas.1600363113","article-title":"Tumor-associated fibroblasts predominantly come from local and not circulating precursors","volume":"113","author":"Arina","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.clbc.2026.08.011_bib0010","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/s41571-021-00546-5","article-title":"Clinical and therapeutic relevance of cancer-associated fibroblasts","volume":"18","author":"Chen","year":"2021","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.clbc.2026.08.011_bib0011","doi-asserted-by":"crossref","first-page":"356","DOI":"10.3389\/fonc.2019.00356","article-title":"Role of exosomes in crosstalk between cancer-associated fibroblasts and cancer cells","volume":"9","author":"Yang","year":"2019","journal-title":"Front Oncol"},{"key":"10.1016\/j.clbc.2026.08.011_bib0012","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/179486","article-title":"Exosome in tumour microenvironment: overview of the crosstalk between normal and cancer cells","volume":"2014","author":"Roma-Rodrigues","year":"2014","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.clbc.2026.08.011_bib0013","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s12943-021-01463-y","article-title":"Cancer associated-fibroblast-derived exosomes in cancer progression","volume":"20","author":"Li","year":"2021","journal-title":"Mol Cancer"},{"key":"10.1016\/j.clbc.2026.08.011_bib0014","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s13238-021-00846-7","article-title":"Metabolic reprogramming and epigenetic modifications on the path to cancer","volume":"13","author":"Sun","year":"2022","journal-title":"Protein Cell"},{"key":"10.1016\/j.clbc.2026.08.011_bib0015","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.cell.2017.05.045","article-title":"Dynamic RNA modifications in gene expression regulation","volume":"169","author":"Roundtree","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.clbc.2026.08.011_bib0016","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.773570","article-title":"N6-methyladenosine RNA modification in the tumor immune microenvironment: novel implications for immunotherapy","volume":"12","author":"Guo","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.clbc.2026.08.011_bib0017","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.molcel.2019.04.025","article-title":"Where, when, and how: context-dependent functions of RNA methylation writers, readers, and erasers","volume":"74","author":"Shi","year":"2019","journal-title":"Mol Cell"},{"key":"10.1016\/j.clbc.2026.08.011_bib0018","first-page":"31","article-title":"METTL3 promotes pancreatic cancer immune escape by m6A modification of lncRNA AFAP1-AS1 to enhance EGR2 stability","author":"Zhu","year":"2026","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.clbc.2026.08.011_bib0019","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12943-021-01447-y","article-title":"METTL3\/IGF2BP3 axis inhibits tumor immune surveillance by upregulating N(6)-methyladenosine modification of PD-L1 mRNA in breast cancer","volume":"21","author":"Wan","year":"2022","journal-title":"Mol Cancer"},{"key":"10.1016\/j.clbc.2026.08.011_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2021.100553","article-title":"Protocol to establish cancer-associated fibroblasts from surgically resected tissues and generate senescent fibroblasts","volume":"2","author":"Yasuda","year":"2021","journal-title":"STAR Protoc"},{"key":"10.1016\/j.clbc.2026.08.011_bib0021","article-title":"PABPN1 as a pan-cancer biomarker: prognostic significance and association with tumor immune microenvironment","volume":"16","author":"Li","year":"2025","journal-title":"Front Immunol"},{"key":"10.1016\/j.clbc.2026.08.011_bib0022","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1007\/s11427-023-2495-x","article-title":"Disruption of PABPN1 phase separation by SNRPD2 drives colorectal cancer cell proliferation and migration through promoting alternative polyadenylation of CTNNBIP1","volume":"67","author":"Hu","year":"2024","journal-title":"Sci China Life Sci"},{"key":"10.1016\/j.clbc.2026.08.011_bib0023","doi-asserted-by":"crossref","first-page":"10531","DOI":"10.7150\/thno.40944","article-title":"Dissecting the heterogeneity of the alternative polyadenylation profiles in triple-negative breast cancers","volume":"10","author":"Wang","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.clbc.2026.08.011_bib0024","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s12943-021-01428-1","article-title":"Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives","volume":"20","author":"Mao","year":"2021","journal-title":"Mol Cancer"},{"key":"10.1016\/j.clbc.2026.08.011_bib0025","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/978-3-030-73119-9_20","article-title":"Osteopontin signaling in shaping tumor microenvironment conducive to malignant progression","volume":"1329","author":"Butti","year":"2021","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.clbc.2026.08.011_bib0026","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/cac2.12291","article-title":"Cancer-associated fibroblasts in breast cancer: challenges and opportunities","volume":"42","author":"Hu","year":"2022","journal-title":"Cancer Commun (Lond)"},{"key":"10.1016\/j.clbc.2026.08.011_bib0027","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/bjc.2013.768","article-title":"Cancer-associated fibroblasts induce epithelial-mesenchymal transition of breast cancer cells through paracrine TGF-\u03b2 signalling","volume":"110","author":"Yu","year":"2014","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clbc.2026.08.011_bib0028","doi-asserted-by":"crossref","first-page":"82889","DOI":"10.18632\/oncotarget.12658","article-title":"Targeting the cancer-associated fibroblasts as a treatment in triple-negative breast cancer","volume":"7","author":"Takai","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.clbc.2026.08.011_bib0029","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.canlet.2018.10.015","article-title":"Cancer-associated fibroblast (CAF)-derived IL32 promotes breast cancer cell invasion and metastasis via integrin \u03b23-p38 MAPK signalling","volume":"442","author":"Wen","year":"2019","journal-title":"Cancer Lett"},{"key":"10.1016\/j.clbc.2026.08.011_bib0030","doi-asserted-by":"crossref","first-page":"4428","DOI":"10.1038\/s41388-018-0263-7","article-title":"Fibroblast-derived CXCL12 promotes breast cancer metastasis by facilitating tumor cell intravasation","volume":"37","author":"Ahirwar","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.clbc.2026.08.011_bib0031","doi-asserted-by":"crossref","first-page":"4692","DOI":"10.1038\/onc.2017.100","article-title":"Aberrant low expression of p85\u03b1 in stromal fibroblasts promotes breast cancer cell metastasis through exosome-mediated paracrine Wnt10b","volume":"36","author":"Chen","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.clbc.2026.08.011_bib0032","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms13050","article-title":"Cancer-associated fibroblast-secreted CXCL16 attracts monocytes to promote stroma activation in triple-negative breast cancers","volume":"7","author":"Allaoui","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.clbc.2026.08.011_bib0033","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.583084","article-title":"Tumor-associated macrophages in tumor immunity","volume":"11","author":"Pan","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.clbc.2026.08.011_bib0034","doi-asserted-by":"crossref","first-page":"3172","DOI":"10.1038\/s41598-019-39553-z","article-title":"Cancer associated fibroblasts sculpt tumour microenvironment by recruiting monocytes and inducing immunosuppressive PD-1(+) TAMs","volume":"9","author":"Gok Yavuz","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.clbc.2026.08.011_bib0035","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s13045-020-00951-w","article-title":"Roles of METTL3 in cancer: mechanisms and therapeutic targeting","volume":"13","author":"Zeng","year":"2020","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.clbc.2026.08.011_bib0036","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1002\/hep.29683","article-title":"RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2","volume":"67","author":"Chen","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.clbc.2026.08.011_bib0037","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1136\/gutjnl-2019-319639","article-title":"METTL3-mediated m(6)A modification of HDGF mRNA promotes gastric cancer progression and has prognostic significance","volume":"69","author":"Wang","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.clbc.2026.08.011_bib0038","doi-asserted-by":"crossref","first-page":"96103","DOI":"10.18632\/oncotarget.21726","article-title":"The m6A methyltransferase METTL3: acting as a tumor suppressor in renal cell carcinoma","volume":"8","author":"Li","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.clbc.2026.08.011_bib0039","doi-asserted-by":"crossref","first-page":"3399","DOI":"10.1038\/s41467-019-11284-9","article-title":"Detailed modeling of positive selection improves detection of cancer driver genes","volume":"10","author":"Zhao","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.clbc.2026.08.011_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2019.144076","article-title":"N6-methyladenosine METTL3 promotes the breast cancer progression via targeting Bcl-2","volume":"722","author":"Wang","year":"2020","journal-title":"Gene"},{"key":"10.1016\/j.clbc.2026.08.011_bib0041","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.canlet.2017.11.018","article-title":"HBXIP-elevated methyltransferase METTL3 promotes the progression of breast cancer via inhibiting tumor suppressor let-7g","volume":"415","author":"Cai","year":"2018","journal-title":"Cancer Lett"},{"key":"10.1016\/j.clbc.2026.08.011_bib0042","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13062-024-00511-z","article-title":"METTL3 in cancer-associated fibroblasts-derived exosomes promotes the proliferation and metastasis and suppresses ferroptosis in colorectal cancer by eliciting ACSL3 m6A modification","volume":"19","author":"Ren","year":"2024","journal-title":"Biol Direct"},{"key":"10.1016\/j.clbc.2026.08.011_bib0043","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/ng0298-164","article-title":"Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy","volume":"18","author":"Brais","year":"1998","journal-title":"Nat Genet"},{"key":"10.1016\/j.clbc.2026.08.011_bib0044","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13578-023-00997-6","article-title":"PABPN1 regulates mRNA alternative polyadenylation to inhibit bladder cancer progression","volume":"13","author":"Chen","year":"2023","journal-title":"Cell Biosci"},{"key":"10.1016\/j.clbc.2026.08.011_bib0045","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1007\/s43032-021-00820-y","article-title":"Exosome-mediated transfer of miR-1323 from cancer-associated fibroblasts confers radioresistance of C33A cells by targeting PABPN1 and activating Wnt\/\u03b2-catenin signaling pathway in cervical cancer","volume":"29","author":"Fang","year":"2022","journal-title":"Reprod Sci"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820926001485?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820926001485?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T05:32:08Z","timestamp":1792215128000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820926001485"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":45,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S1526820926001485"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2026.08.011","relation":{},"ISSN":["1526-8209"],"issn-type":[{"value":"1526-8209","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cancer-Associated Fibroblasts-Derived Exosomal METTL3 Drives Breast Cancer Malignancy by Eliciting PABPN1 m6A Modification","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2026.08.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}